Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 67.6 CNY -0.5%
Market Cap: 50.1B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note

Hangzhou Tigermed Consulting Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hangzhou Tigermed Consulting Co Ltd
Gross Profit Peer Comparison

Comparables:
603259
300759
2269
M
688114
W
2268

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Gross Profit
ÂĄ2.7B
CAGR 3-Years
15%
CAGR 5-Years
18%
CAGR 10-Years
30%
WuXi AppTec Co Ltd
SSE:603259
Gross Profit
ÂĄ15.4B
CAGR 3-Years
27%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Gross Profit
ÂĄ3.8B
CAGR 3-Years
19%
CAGR 5-Years
30%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Gross Profit
ÂĄ6.6B
CAGR 3-Years
18%
CAGR 5-Years
39%
CAGR 10-Years
N/A
M
MGI Tech Co Ltd
SSE:688114
Gross Profit
ÂĄ1.5B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Gross Profit
ÂĄ559.6m
CAGR 3-Years
310%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hangzhou Tigermed Consulting Co Ltd's Gross Profit?
Gross Profit
2.7B CNY

Based on the financial report for Jun 30, 2024, Hangzhou Tigermed Consulting Co Ltd's Gross Profit amounts to 2.7B CNY.

What is Hangzhou Tigermed Consulting Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
30%

Over the last year, the Gross Profit growth was -6%. The average annual Gross Profit growth rates for Hangzhou Tigermed Consulting Co Ltd have been 15% over the past three years , 18% over the past five years , and 30% over the past ten years .

Back to Top